SomeNCIt concept

https://www.anses.fr/fr/system/files/BIORISK2021SA0019Ra.pdf
https://www.anses.fr/fr/system/files/BIORISK2021SA0019Ra-Anx-13.pdf
2024
France
technical report
cost savings
protestantism
Adverse Event Definitely Related to Intervention
judgment
Some
bays
albumin/globulin ratio
genomics
Genome
Economics
Medium Growth Rate
Approximate
risk
CDISC SDTM Protocol Risk Assessment Response Codelist
Device Evaluation Method
Relative Risk
Evaluation Method
economics
relative risk
Obtain
A Medium Amount of Time
environment
Growth Medium
Media
socioeconomic factors
health risk appraisal
hazardous substances
Medium Heart Murmur
evaluation report
plant, nos
Moderately Bothered
plants
Technique
Environmental
Health Risk Assessment
Certain
Hazard Ratio
genome
evaluation studies as topic
Plant
genome, plant
Neither Agree or Disagree
Middle Lobe of the Prostate
genome, nos
Middle
Surrounding
inlets
health status indicators

---
https://www.health.belgium.be/fr/avis-9801-nouvelles-techniques-genomiques-ngts
2024
Belgium
technical report
Tumor Necrosis Factor Ligand Superfamily Member 15
proposita
Middle
genome, nos
Moderately Bothered
Medium Heart Murmur
genome
Some
Adverse Event Definitely Related to Intervention
A Medium Amount of Time
Middle Lobe of the Prostate
Medium Growth Rate
plants
Technique
Genome
social control, formal
Media
genomics
Proposal
TNFSF15 wt Allele
Certain
Growth Medium

---
https://www.health.belgium.be/fr/avis-9754-ar-interdiction-dexportation-de-substances-dangereuses
2023
Belgium
technical report
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
No History of Non-Cardiac Surgery
Nitric Oxide Measurement
ERBB2 Mutation Analysis Was Not Performed
Negation
ATRX Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
Certain
Unemployed
No History of Neonatal Complication
Some
PTEN Mutation Analysis Was Not Performed
hazardous substances
Minor Criteria for Rheumatic Heart Disease Not Present
Chief Complaint Not Caused by Trauma
Extremity Part
Radiation Therapy Not Received
MGMT Promoter Methylation Testing Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
NRAS Mutation Analysis Was Not Performed
Version
Documentation Absent
Murine Limb
Projected
BRAF Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
CDISC SEND Country Terminology
ATRX Gene Mutation Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Gestational Complication
10q23/PTEN Locus Deletion Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Paraneoplastic Syndrome is Not Present
Chief Complaint was Not Witnessed
Export
PTEN Gene Mutation Negative
Tumor Reoccurrence Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
No History of Congenital Heart Disease
Any Metastatic Diagnosis Absent
all extremities
First Degree Family History Cancer Negative
european union
Other Preoperative IV Medications were not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
History of Colorectal Cancer Negative
First Degree Family History of Primary Brain Tumor Negative
Caffeine Not Routinely Consumed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Projection
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Substance
Medication Not Taken
Hypertension Absent
Chemotherapy Not Received
Evidence of Disease Absent after Completion of Therapy
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
SDH Complex Mutation Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Chemical/Occupational Exposure Absent
extremities
Cancer History Absent
EGFR Amplification Analysis Was Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No Response to Intervention for Kawasaki Disease
History of Medical Treatment Absent
KRAS Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
No History of Kawasaki Disease
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Neither Case or Control Status
Routine Cytogenetics Were not Completed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Disease is not Multifocal
Nitric Oxide
No History of Myopathy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Adverse Event Definitely Related to Intervention
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
Radiation History Negative
Preoperative IV Opiates were not Administered
MET Mutation Analysis Was Not Performed
Neither
Therapeutic Ionizing Radiation to Head History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
Additional Surgery for New Tumor Event Absent
No History of Rheumatic Fever
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Membership
Country Code
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
Netherlands
1p/19q Deletion Analysis Was Not Performed
Has No Sibling
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Norway
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
NF1 Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Preoperative IV Sedation was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Tumor Progression Absent After Initial Treatment
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Physician Diagnosed Diabetes Absent
Preoperative IV Antacids were not Administered
EGFR Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Additional Molecular Studies Were Not Performed
Preoperative IV Antiemetics were not Administered
Discontinue
Adjuvant Post-operative Immunological Therapy Was Not Administered
European Union
EGFR Gene Amplification Negative
Additional Immunohistochemistry Was Not Performed
IDH Family Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use

---